NCT06868953View on ClinicalTrials.gov

Use of the Combination of Sumatriptan and Naproxen in the Acute Treatment of Migraine: Real World Evidence Study

Not yet recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

April 10, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Migraine

Interventions

DRUG

combination of sumatriptan 85 mg and naproxen 500 mg

All Listed Sponsors

lead

IRCCS San Raffaele Roma

OTHER

NCT06868953 - Use of the Combination of Sumatriptan and Naproxen in the Acute Treatment of Migraine: Real World Evidence Study | Biotech Hunter | Biotech Hunter